HIV, Tuberculosis, Hepatitis B, and Hepatitis C: Drugs, Diagnostics, Vaccines, and Microbicides in Development by Lei Chou, Mark Harrington, Bob Huff, Richard Jefferys, Tracy Swan, Javid Syed, and Claire Wingfield This Report was released at the XVII International AIDS Conference…
Battling the Dual Epidemic through Community Action AUGUST 2008 TB/HIV: What Every HIV/AIDS Activist Should Know by Nelson Juma Otwoma I have always wanted to make a difference. My activism took root in my home province, Nyanza. My activism has…
A Critical Analysis of Funding Trends, 2005–2006: An Update By Cindra Feuer July 2008 - The Treatment Action Group (TAG) report on tuberculosis (TB) research and development (R&D) in 2006 finds that while funding for TB research increased from 2005…
Experiences & Leadership by AIDS Activists Compiled by Public Health Watch (PHW) and Treatment Action Group (TAG) 2008 Introduction The Open Society Institute’s Public Health Watch (PHW)1 and Treatment Action Group (TAG)2 began working together through a common desire to…
By Mark Harrington Winter 2007 Mark Harrington, executive director of the Treatment Action Group, in an opinion published in the Cape Times argues that we are living in a time of potentially great scientific accomplishments ... but we are missing…
Experimental Treatments and Preventive Therapies for HIV, Hepatitis C, and Tuberculosis: By Mark Harrington, Bob Huff, and Richard Jefferys. Reviewed by Tracy Swan, Javid Syed, Claire Wingfield, and Jen Curry.
Tuberculosis Research & Development: A Critical Analysis By Cindra Feuer October 2006 - This report is the product of an effort by the Treatment Action Group (TAG) to ascertain the major funders of tuberculosis (TB) research and development (R&D) in…
What’s in the Pipeline: New HIV Drugs, Vaccines, Microbicides, HCV and TB Therapies in Clinical Trials By Rob Camp, Richard Jefferys, Tracy Swan & Javid Syed Edited by Bob Huff August 2006 From the Forword: Twenty-five years into the global…